What can be used to decrease tremors caused by Lexapro (escitalopram)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Lexapro-Induced Tremors

Beta-blockers, specifically propranolol, are the first-line pharmacological treatment for tremors caused by Lexapro (escitalopram), with typical starting doses of 10-20mg twice daily and maximum benefit usually achieved between 160-320mg/day. 1, 2, 3

Understanding the Mechanism

  • SSRIs like escitalopram commonly cause tremor as a dose-related adverse effect through serotonergic mechanisms that enhance physiological tremor 4, 1
  • Tremors from SSRIs typically manifest as postural tremors affecting the hands and arms, though jaw tremors have also been reported with related medications like citalopram 5
  • The American Academy of Family Physicians recognizes sweating, tremors, and nervousness as typical side effects across the entire SSRI drug class 4, 1

Treatment Algorithm

Step 1: Assess Severity and Timing

  • If tremor occurred early in treatment or after a dose increase, consider dose reduction or slower up-titration as the initial strategy 1
  • Evaluate whether the patient is on a dose above 20mg daily (the FDA-approved maximum), as higher doses increase side effect risk 6

Step 2: Pharmacological Management

Propranolol (First-Line)

  • Start with 10-20mg twice daily and titrate upward as needed 3
  • Maximum tremor suppression typically occurs between 160-320mg/day, with doses above this rarely providing additional benefit 7
  • Monitor for contraindications including asthma, severe COPD, heart block, or bradycardia 3

Alternative Beta-Blockers

  • Other beta-blockers can be considered if propranolol is not tolerated, though propranolol has the strongest evidence base 8, 3

Second-Line Options (if beta-blockers contraindicated or ineffective)

  • Primidone: effective for tremor control 3
  • Gabapentin: can reduce tremor amplitude 3
  • Benzodiazepines: may provide modest benefit but carry dependency risk 3

Step 3: Dose Optimization of Escitalopram

  • If tremor persists despite propranolol and the patient is on 20mg or higher, gradually taper escitalopram by 5mg every 1-2 weeks to minimize discontinuation symptoms 6
  • Consider augmentation strategies rather than exceeding 20mg daily, such as adding bupropion or mirtazapine (though note these can also cause tremor) 4, 6
  • Alternatively, switch to an SNRI like venlafaxine or duloxetine, though these also carry tremor risk through similar mechanisms 1, 6

Critical Pitfalls to Avoid

  • Do not abruptly discontinue escitalopram without tapering over 10-14 days, as this causes withdrawal symptoms 4
  • Do not combine multiple serotonergic medications without careful monitoring, as this increases risk of serotonin syndrome (which includes tremor as a symptom but requires immediate hospitalization) 1
  • Do not exceed propranolol 320mg/day expecting additional tremor benefit, as higher doses increase side effects without improving efficacy 7
  • Do not overlook cardiac monitoring if propranolol doses exceed 160mg/day, particularly in elderly patients 3

Special Considerations

  • Elderly patients are more susceptible to medication side effects and may require lower starting doses of both escitalopram and propranolol 4, 6
  • Approximately 63% of patients on SSRIs experience at least one adverse effect, so tremor should be anticipated and proactively discussed 1
  • If the patient has cardiac risk factors, obtain an ECG before initiating propranolol and monitor QT interval if escitalopram dose is near or at maximum 6

References

Guideline

Medication-Induced Tremors

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Drug-induced tremors.

The Lancet. Neurology, 2005

Research

Postural induced-tremor in psychiatry.

Psychiatry and clinical neurosciences, 2008

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Citalopram-induced jaw tremor.

Clinical neurology and neurosurgery, 2004

Guideline

Managing Escitalopram Dosage

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Treatment of valproate tremors.

Neurology, 1983

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.